← Back to All US Stocks

EVOXU Stock Analysis 2026 - Evolution Global Acquisition Corp AI Rating

EVOXU Nasdaq Blank Checks E9 CIK: 0002077954
Recently Updated • Analysis: Mar 24, 2026 • SEC Data: 2025-12-31
STRONG SELL
95% Conf
Pending
Analysis scheduled

📊 EVOXU Key Takeaways

Revenue: N/A
Net Margin: N/A
Free Cash Flow: $-263.4K
Current Ratio: 7.23x
Debt/Equity: N/A
EPS: $-0.01
AI Rating: STRONG SELL with 95% confidence

Is EVOXU a Good Investment? Thesis Analysis

Claude

Evolution Global Acquisition Corp is a blank check company with severe financial distress, evidenced by negative stockholders equity of -8.5M, accumulated operating losses, and negative free cash flow. The company demonstrates no revenue generation, no assets deployed operationally, and is effectively insolvent on a book value basis, making it unsuitable for fundamental analysis as a going concern.

Why Buy EVOXU? Key Strengths

Claude
  • + High current ratio of 7.23x indicates adequate short-term liquidity from cash reserves
  • + Total assets of 242.5M suggest trust account remains intact from SPAC capital raise
  • + Low absolute liabilities of 9.8M relative to asset base

EVOXU Investment Risks to Consider

Claude
  • ! Negative stockholders equity of -8.5M indicates the company is technically insolvent and equity has been depleted
  • ! No revenue and no apparent business operations indicate entity remains unfunded blank check with no merger target
  • ! Negative free cash flow of -263.4K and ongoing operating losses demonstrate cash burn with no revenue to sustain operations
  • ! Minimal insider activity suggests lack of confidence and potential impending liquidation or dissolution
  • ! Extended period without merger consummation threatens trust account redemption and equity value destruction

Key Metrics to Watch

Claude
  • * Trust account balance and redemption pressure timeline
  • * Stockholders equity trajectory and path to positive book value
  • * Operating cash burn rate and cash runway
  • * Merger or business combination announcement (if any)

EVOXU Financial Metrics

Revenue
N/A
Net Income
$-4.1M
EPS (Diluted)
$-0.01
Free Cash Flow
$-263.4K
Total Assets
$242.5M
Cash Position
$1.1M

💡 AI Analyst Insight

Strong liquidity with a 7.23x current ratio provides a solid financial cushion.

EVOXU Profitability Ratios

Gross Margin N/A
Operating Margin N/A
Net Margin N/A
ROE N/A
ROA -1.7%
FCF Margin N/A

EVOXU vs Default Sector

How Evolution Global Acquisition Corp compares to Default sector averages

Net Margin
EVOXU 0.0%
vs
Sector Avg 12.0%
EVOXU Sector
ROE
EVOXU 0.0%
vs
Sector Avg 15.0%
EVOXU Sector
Current Ratio
EVOXU 7.2x
vs
Sector Avg 1.8x
EVOXU Sector
Debt/Equity
EVOXU 0.0x
vs
Sector Avg 0.7x
EVOXU Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is EVOXU Overvalued or Undervalued?

Based on fundamental analysis, Evolution Global Acquisition Corp has mixed fundamental signals relative to the Default sector in 2026.

Return on Equity
N/A
Sector avg: 15%
Net Profit Margin
N/A
Sector avg: 12%
Revenue Growth
N/A
Year-over-year
Debt/Equity
N/A
Sector avg: 0.7x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

EVOXU Balance Sheet & Liquidity

Current Ratio
7.23x
Quick Ratio
7.23x
Debt/Equity
N/A
Debt/Assets
4.0%
Interest Coverage
N/A
Long-term Debt
N/A

EVOXU 5-Year Financial Trend & Growth Analysis

EVOXU 5-year financial data:
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: Evolution Global Acquisition Corp's revenue has remained relatively flat over the 5-year period, with a 0% decline.

EVOXU Growth Metrics (YoY)

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
N/A
Free cash flow / Revenue

EVOXU Capital Allocation

Operating Cash Flow
-$263.4K
Cash generated from operations
Dividends
None
No dividend program

EVOXU SEC 10-K & 10-Q Filing Analysis

Access official SEC EDGAR filings for Evolution Global Acquisition Corp (CIK: 0002077954)

📋 Recent SEC Filings

Date Form Document Action
Mar 13, 2026 8-K ea0281585-8k_evolution.htm View →
Mar 3, 2026 10-K ea0273613-10k_evolution.htm View →
Dec 16, 2025 10-Q ea0268843-10q_evolution.htm View →
Dec 3, 2025 8-K ea0268166-8k_evolution.htm View →
Dec 1, 2025 8-K ea0267902-8k_evolution.htm View →

Frequently Asked Questions about EVOXU

What is the AI rating for EVOXU?

Evolution Global Acquisition Corp (EVOXU) has an AI rating of STRONG SELL with 95% confidence, based on fundamental analysis of SEC EDGAR filings.

What are EVOXU's key strengths?

Claude: High current ratio of 7.23x indicates adequate short-term liquidity from cash reserves. Total assets of 242.5M suggest trust account remains intact from SPAC capital raise.

What are the risks of investing in EVOXU?

Claude: Negative stockholders equity of -8.5M indicates the company is technically insolvent and equity has been depleted. No revenue and no apparent business operations indicate entity remains unfunded blank check with no merger target.

What is EVOXU's revenue and growth?

Evolution Global Acquisition Corp reported revenue of N/A.

Does EVOXU pay dividends?

Evolution Global Acquisition Corp does not currently pay dividends.

Where can I find EVOXU SEC filings?

Official SEC filings for Evolution Global Acquisition Corp (CIK: 0002077954) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is EVOXU's EPS?

Evolution Global Acquisition Corp has a diluted EPS of $-0.01.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.

Is EVOXU a good stock to buy right now?

Based on our AI fundamental analysis in March 2026, Evolution Global Acquisition Corp has a STRONG SELL rating with 95% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.

Is EVOXU stock overvalued or undervalued?

Valuation metrics for EVOXU: ROE of N/A (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.

Should I buy EVOXU stock in 2026?

Our dual AI analysis gives Evolution Global Acquisition Corp a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.

What is EVOXU's free cash flow?

Evolution Global Acquisition Corp's operating cash flow is $-263.4K, with capital expenditures of N/A.

How does EVOXU compare to other Default stocks?

Vs Default sector averages: Net margin N/A (avg: 12%), ROE N/A (avg: 15%), current ratio 7.23 (avg: 1.8).

Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Mar 24, 2026 | Data as of: 2025-12-31 | Powered by Claude AI